Navigation Links
Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna

AUSTIN, Texas, Sept. 26, 2011 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX), today announced that it will host Planet xMAP Europe 2011, its annual European multiplexing technology symposium, September 28-29, 2011, at The Hofburg in Vienna, Austria. The event will feature scientific sessions, workshops, discussion groups, exhibitions and networking events with scientists and researchers from around the world who are performing groundbreaking work in clinical diagnostics and life science research using the Luminex xMAP® multiplexing technology platform.  


"Key areas of focus for this year's symposium include pathogen detection, immunology-monitoring, human genetics, protein and nucleic acid research," said Paul C. Ladestein, General Manager European Operations for Luminex. "Planet xMAP Europe is an excellent opportunity for leading scientists to gather and exchange ideas on how xMAP multiplexing technology is revolutionizing their laboratories and research."

xTAG® GPP is only one example of the innovations in molecular diagnostics that highlights this year's agenda. CE marked xTAG GPP, the only test to simultaneously detect and identify up to 95 percent of the disease causing bacterial, viral and gastroenteritis pathogens in a single test, was used as a front-line test during the recent German outbreak of a novel E. coli strain.

Planet xMAP Europe 2011 will feature two days of presentations with focused session options.  

Day One of Planet xMAP Europe 2011, Wednesday, 28 September, will focus on Pathogen Detection, the xTAG Gastrointestinal Pathogen Panel (GPP), Immunology-Monitoring, and HLA-Human Genetics.The morning session will include the following presentations:

Eugene Halligan, Ph.D., St. Thomas' Hospital, London, UK, "An evaluation of the Luminex xTAG® Gastrointestinal Pathogen Panel at a London teaching hospital 2011: The comparative performance of a rapid molecular multiplex assay and current standard laboratory investigations for gastroenteritis"

Matthew Albert, M.D., Head, Laboratory of Dendritic Cell Immunobiology, Director, Department of Immunology, Pasteur Institute, Paris, France, "How biomarker discovery can lead to new insights into disease pathogenesis and new therapeutic targets for chronic HCV infection"

Morten Ruhwald, M.D., Hvidovre Hospital, Copenhagen, Denmark, "Immuno-diagnosis of tuberculosis infection using IP-10"

Prof. Jean-Louis Merlin, Unite de Biologie des Tumeurs, Nancy, France, "Phosphoprotein array assay companion diagnostics for response prediction to monoclonal antibodies and kinase inhibitors in oncology"

Holly Soares, Ph.D., Director Neuroscience Clinical Biomarkers Group, Bristol-Myers Squibb, Wallingford, CT, USA, "Use of multiplex panels to identify novel CSF and plasma biomarkers of Alzheimer's disease"

The afternoon session will feature three separate tracks focused on Human Genetics, Immunology-Monitoring, and Pathogen Detection.

Day Two of Planet xMAP Europe 2011, Thursday, 29 September, will focus on Genomic and Protein Research.The morning session will include the following presentations:

John E. Connolly, Ph.D., Director, Program in Translational Immunology Principal Investigator, Singapore Immunology Network (SIgN), "Systems Approaches to Monitoring Immune Responses in Clinical Trials"

Prof. Dr. Matthias Mack, Institute for Technical Microbiology, Mannheim University of Applied Sciences, Mannheim, Germany, "A high-throughput microtiter plate-based screening method for the detection of full-length recombinant proteins"

Alina Deshpande, Ph.D., D-3, Systems Engineering and Integration Decision, Applications Division, Los Alamos, NM, USA, "Multiplexed Nucleic Acid-Based Assays for Human Disease Diagnosis"

Prof. Christophe Sola, Microbiology and Genetic Institute UMR8621, Orsay University, Paris, France, "CRISPR and RNA characterization on microspheres for academic and operational research in microbiology"

Tom Copa, Vice President, Life Science Research & Food Safety, Luminex Corporation, Austin, TX, USA, "It's About Time"

The afternoon session will feature two separate tracks focused on Genomic Research and Protein Research.

For detailed information regarding the Planet xMAP Europe 2011 symposium and agenda, or to register online, please visit About Luminex CorporationLuminex is committed to applying its passion for innovation to advancing healthcare and research worldwide.  We are transforming global healthcare and life-science research through the development, manufacturing, and marketing of proprietary instruments and assays utilizing our xMAP open-architecture, multi-analyte platform and our MultiCode real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies that deliver cost-effective and rapid results to clinicians and researchers.  Our technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies.  We are meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety.  For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology please visit our website at Corporate:

Media:Harriss T. Currie

Mimi TorringtonChief Financial Officer and Vice President, Finance

Director, Marketing CommunicationsLuminex Corporation



512.219.8020Investors:Matthew Scalo

Leslie DensonSr. Director, Investor Relations

Porter NovelliLuminex Corporation


SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Corporation to Present at Upcoming Investment Conferences In September
2. Luminex Corporation Reports Second Quarter 2011 Results
3. Luminex Corporation Receives U.S. FDA Clearance for New, Front Line Respiratory Viral Panel Test
4. Luminex Corporation Second Quarter Earnings Release Scheduled for August 8, 2011
5. Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
6. Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System
7. Luminex Corporation Announces Agreement to Acquire EraGen Biosciences, Inc.
8. Luminex and Life Technologies Sign Agreement for Global Distribution of the Award-Winning MAGPIX® Multiplexing Instrument
9. Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference
10. Luminex Corporation Reports First Quarter 2011 Results
11. Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011
Post Your Comments:
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... nuevo enfoque combina la inmunoterapia con la terapia fotodinámica ... Clinical Cancer Research . --> Clinical ...
(Date:11/26/2015)... 26 november 2015 AAIPharma Services ... geplande investering aan van ten minste $15,8 ... en het mondiale hoofdkantoor in ... resulteren in extra kantoorruimte en extra capaciteit ... groeiende behoeften van de farmaceutische en biotechnologische ...
(Date:11/26/2015)... , November 26, 2015 ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... has found that immunotherapy can be efficiently ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point ... come together on Thanksgiving Day to share the things that they are most ... Serenity Point YouTube channel, patients displayed what they wrote on index cards, describing ...
(Date:11/26/2015)... ... ... Inevitably when people think Thanksgiving, they also think Holiday sales and start ... and Cyber Monday massage chair sales to receive the best pricing on ... find the best massage chair deals, they can see all of the coupons in ...
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... Representative. As a franchise owner, Somu now offers travelers, value and care based ... packages, private cruise sales, as well as, cabin upgrades and special amenities such ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug ... need to integrate dose form selection in early phase drug development. The first ... supporting and bringing together the UK’s emerging life sciences companies, corporate partners, and ...
Breaking Medicine News(10 mins):